AHG · Akso Health Group
Price & Indicators
Up next
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Distribution — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
AHG
this stock
Akso Health Group
|
$1.37B | -2.4% | +119.7% | — | 0.0% |
|
MCK
Mckesson Corp
|
$99.63B | +1.1% | +3.1% | 21.6 | 3.4% |
|
COR
Cencora, Inc.
|
$58.97B | -10.1% | +9.3% | 23.2 | 2.8% |
|
CAH
Cardinal Health Inc
|
$53.44B | +11.1% | -1.9% | — | 3.0% |
|
HSIC
Henry Schein Inc
|
$9.78B | +13.6% | +5.9% | 25.9 | 6.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| AHG | +5.3% | +19.4% | +11.9% | +7.4% | -2.4% |
| SPY | -0.5% | +0.5% | +7.6% | +0.2% | +9.7% |
| vs SPY | +5.7% | +18.9% | +4.3% | +7.2% | -12.2% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.